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ABSTRACT
Objective: To study the efficacy and advantage in using autologus platelet rich
plasma   during   myringoplasty   in   closure   of   tympanic   membrane   perforation
preventing the graft displacement, promoting quicker healing & improving overall
outcome.
Methods : Platelet rich plasma(PRP) is an autologus platelet rich concentrate 
prepared from patients own blood  with growth factors up to 8 times that of normal
serum and its efficacy when used during myringoplasty is studied.50 patients with 
chronic otitis media inactive mucosal disease were randomly chosen and 25 of 
them was the study group and other 25 were the control group. Both group patients
underwent myringoplasty and PRP was used in the study group and the results 
were evaluated.
Results: In our study among 25 cases that underwent myringoplasty with use of 
platelet rich fibrin, 24 had complete tympanic membrane closure and only one 
failure has been noticed. In controls 5 out of 25 cases had failure. The graft take up
rate in our study is comparable with the reference studies. Use of PRP accelerates 
graft uptake.
Conclusion: Platelet rich plasma is a cheap and cost effective platelet concentrate 
with enriched growth factors. It accelerates the tympanic membrane closure 
following myringoplasty.
Keywords: Platelet rich plasma, myringoplasty, Autologous.INTRODUCTION
                              Chronic suppurative otitis media is defined as chronic
inflammation of the mucoperiosteal lining of the middle ear cleft. It is associated
with persistent or intermittent discharge through a non intact tympanic membrane.
It is prevalent in developing countries like India and is more common in lower
socio economic groups. The incidence is very high among rural population than in
urban population
4. The overall prevalence rate is 46 and 16 persons per thousand in
rural and urban population. Both anatomical and functional obstruction of the
Eustachian tube can lead to failure of its functions which can result in otitis media
1.
Tympanic membrane perforation may result from AOM, chronic otitis media, or
trauma (injury or surgery). In some instances, a dry, simple perforation results from
a single episode of AOM (i.e., necrotizing otitis media). In our study we analyze
the case of chronic otitis media mucosal type only which is one of the common
diseases seen in ENT OPD.
MATERIALS AND METHODS
                          Platelet rich plasma was first used in cardiothoracic surgery.
M.Ferari used platelet rich plasma in 1987 after an open heart surgery. Now it is
widely used in various fields like dentistry, orthopedics, otorhinolaryngology,maxillofacial surgery, dermatology, plastic and cosmetic surgery, urology, wound
healing etc
2. 
                        Platelet isolated from the blood forms a rich autologus source of
growth factors. When these platelets are concentrated and applied to the surgical
site more predictable outcome can be expected. Platelet rich plasma is such an
autologus platelet concentrate. A blood clot is the important factor in soft tissue
healing in all natural wounds. Platelet rich plasma is a similar strategy where
platelet concentrate which is an enriched natural blood clot is produced which
initiate a more rapid and complete healing process. A natural blood clot usually
contains 95% RBC’s, 5% platelets, and less than one percent of white blood cells
and numerous amount of fibrin strands. A platelet rich plasma blood clot contains
95% of platelet, 4% of RBC’s and 1% of WBC’s
9.
              
 PREPARATION OF PRP:
PRP can be prepared by two techniques
3.
      1. General-purpose cell separators
      2. Platelet-concentrating cell separators
1. General-purpose cell separators:
                    They require large amount of blood (450 ml) and requires good
hospital setup. Blood is drawn into the collection bag which contains citratephosphate-dextrose anticoagulant and is first centrifuged at 5,600 rpm to separate
RBCs from platelet to get platelet poor plasma (PPP) and platelet rich plasma
( PRP). Next the centrifugation speed is reduced to 2,400 rpm and final separation
of about 30 ml of PRP is obtained from the RBCs. The remaining PPP and RBCs
can be returned to the patient's body or can be discarded.
1. Platelet-concentrating cell separators:
                         They require small quantity of blood and can be prepared by in
clinic itself. The preparation and the processing of PRP are similar in most of the
platelet-concentrating systems but the anticoagulant used and the speed and
duration of centrifugation might differ with different systems.
1. Venous blood is taken into a tube containing an anticoagulant which avoids
platelet activation and degranulation.
2. The first centrifugation is a "soft spin", which separates blood into three layers,
namely bottom-most layer containing RBC (55% of total volume), top most
acellular layer called Platelet Poor Plasma- PPP  (40% of total volume), and an
intermediate Platelet Rich Plasma layer (5% of total volume) called the "Buffy
coat".
3. Using a syringe PPP, PRP and some RBCs are transferred into another tube
without an anticoagulant. 4. This tube now undergoes a second centrifugation; it is longer and faster than the
first one, so called "hard spin". This allows the PRP to settle at the bottom of the
tube with a very few RBCs. The acellular plasma (80% of the volume) is found at
the top.
5. PPP is removed with a syringe and discarded and the remaining PRP is shaken
well.
6. This PRP is mixed with bovine thrombin & calcium chloride during the time of
application which results in gelling of this platelet concentrate. 
SIDE EFFECTS OF PRP:
                     Since it is an autologous preparation, PRP is inherently safe and
therefore it is free from transmissible diseases such as HIV, Hepatitis etc
9. During
the preparation of PRP calcium chloride and bovine thrombin are used. It has been
found that the use of this bovine thrombin can lead to the development of
antibodies to the factors V, XI and thrombin which results in the risk of life
threatening coagulopathies. Bovine thrombin preparation contains factor V, which
can result in the stimulation of immune system when challenged with a new
protein.                  
PLATELET RICH FIBRIN (PRF):
                               PRF was first developed by Choukroun et al in France. It is
usually called as second generation platelet rich plasma
8. It has several advantages
over traditional PRP. The chief advantages are
· The ease of preparation and 
· The absence of biochemical handling of the blood, which makes this
preparation purely autologous.
PREPARATION OF PRF:
                          The preparation of PRF is very simple procedure. Since we do not
use bovine thrombin for the preparation; PRF is free from the associated risks. 
· The required quantity of blood is taken into 10ml test tubes 
· No anticoagulant is added. 
· It is centrifuged immediately. 
· Blood is centrifuged using a tabletop centrifuge, which is easily available in
most of the labs.
· It is centrifuged for 12 min at 2,700 rpm. 
The resultant product consists of the following three layers:
· Topmost layer consisting of acellular Platelet poor plasma.
· PRF clot is in the middle
· RBCs at the bottom
9.                             Because of the absence of the anticoagulant, blood begins to
coagulate very soon when it comes in contact with the glass surface. So for
successful   preparation   of   PRF,   quick   blood   collection   and   centrifuging   it
immediately before the clotting cascade is initiated is necessary. PRF can be
applied to surgical site. In our study we have used this second generation platelet
                                            
                          Fig 1 platelet rich fibrin preparation     
                       
 Fig 2 Middle PRF layer
rich concentrate. The growth factor content (PDGF and TGF-β) was comparable in
both PRF and PRP. PRF has many advantages over usually prepared PRP. It
eliminates adding anticoagulant and neutralizing it. The addition of bovine-derived
thrombin which promotes the conversion of fibrinogen to fibrin in PRP is also
eliminated. All these steps considerably reduce biochemical handling of blood and
reduce the risk associated with the bovine derived thrombin. The conversion of
fibrinogen   into   fibrin   occurs   slowly   with   the   available   small   quantities   of
physiological thrombin present in the blood sample itself. Thus there is a normal
physiologic architecture which is very favorable to the healing which is obtained
due to this slow polymerization process
7.
                   Our study is a Cohort study / Prospective Observational study of
myringoplasty done in our institution, in patients with chronic otitis media inactivemucosal disease (central perforation with dry ear).Children below 12 years of age ,
Active ear disease, Atopic ear conditions, Diabetes mellitus, Other systemic illness
like autoimmune disease, active neoplastic disease , Patient on immunosuppressant
drugs were excluded from the study. Patient in whom platelet rich plasma is not
used for myringoplasty during the same study period are taken as control group.
                       Patient with chronic otitis media mucosal disease were randomly
selected from the OPD of our institution. They were first subjected to examination
under microscope. Ear examination with the aid of microscope is the gold standard
for diagnosis of COM
1.Pus was sent for culture and sensitivity. The bacteriological
culture is of potential value in starting specific antibiotics. All the patients with
active ear  disease were treated up to one month with specific  antibiotics.
Diagnostic nasal endoscopy was done for all patients. Those who had nasal
obstruction and features of chronic sinusitis were subjected to computerized
tomography of paranasal sinus. Patients with persistent symptoms and signs of
chronic   sinusitis   after   adequate   medical   treatment   underwent   Functional
endoscopic sinus surgery with or without septal correction. Pure tone audiogram is
done in all patients which is helpful in assessing degree and type of hearing loss.
                     After achieving dry ear for six to eight weeks, patient is subjected to
X-ray of both mastoids – Law’s view or lateral oblique view. X-ray showed
sclerotic mastoid or clouding of air cells or cellular mastoid. Depending upon theX-ray finding the surgical procedure was planned. Patients with sclerosed mastoids
and clouding of air cells underwent cortical mastoidectomy with myringoplasty
with or without ossicular reconstruction. Patients with cellular mastoid underwent
myringoplasty   alone   with   or   without   ossicular   reconstruction
5.   Under   lay
myringoplasty was done and platelet rich fibrin was placed over the myringoplasty
site.
                          
Fig 3 underlay myringoplasty done and  PRF placed in myringoplasty site.
 DISCUSSION
         In our study out of the 50 patients who underwent surgery, 30 were females
(60 percent) and 20 (40 percent) were males. The disease is common in 20 to 30
yrs age group in our study population. This disease  is more common in lowersocioeconomic group  due to overcrowding, poor sanitation, poor nutrition and
illiteracy.
                       About 84 percent (42 patients) of people in the study population had
unilateral ear disease whereas remaining 16 percent (8 patients) had bilateral
disease. In study cases 19 patients had unilateral disease and 6 patients had
bilateral disease. In controls 23 patients had unilateral disease whereas 2 patients
had bilateral disease. Among the unilateral disease in controls 13 patients had right
ear disease whereas 10 patients had left ear disease. Among study cases 7 patients
had right ear disease and 12 patients had left ear disease. Bilateral disease is
commonly due to bilateral Eustachian tube dysfunction.
                         In our study large and subtotal perforation is very common in
comparison to other perforations. Among cases 2 patients had small perforation, 7
patients had medium, 6 patients had large and 10 patients had subtotal perforation.
In controls 3 small, 2 medium, 11 large and 9 subtotal perforations was seen.
According to the study conducted by  Braccini F  regarding the  relevance of
Choukroun's Platelet-Rich Fibrin (PRF)   during   middle   ear   surgery   residual
perforations were noticed in 4 percent of cases, all of them had large perforation
preoperatively. Out of 6 failures in our study 5 occurred in large/ subtotal
perforations which is similar to the above study.                                 X – Ray both mastoids was the important investigation based
on   which   surgery   for   the   patient   is   decided.   All   patients   underwent   this
investigation after attaining dry ear for 6 to 8 weeks.  Among cases 12 patients had
well pneumatised mastoids, they underwent myringoplasty and 13 had sclerosed
mastoids or clouding of air cells, they underwent cortical mastoidectomy with
myringoplasty. Among control 6 patients had well pneumatised mastoids whereas
19 had sclerosed mastoids.
                        The graft take up rate in our study is comparable with the reference
studies. According to Maria Luisa Navarrete Alvaro use of platelet rich plasma
during myringoplasty had a satisfactory result
2. A study was conducted by Mehmet
Habesoglu M.D in 2011 among 32 patients  with acute tympanic membrane
perforations. He concluded that use of platelet rich fibrin accelerated the tympanic
membrane closure. In our study among 25 cases that underwent myringoplasty
with use of platelet rich fibrin, 24 had complete tympanic membrane closure and
only one failure has been noticed. In controls 5 out of 25 cases had failure. At the
end of first month follow up, 72 percent of cases had closure of tympanic
membrane, while only 40 percent of controls had tympanic membrane closure. At
the end of second month 92 percent of cases had closure while only 72 percent of
control had closure. At the end of 3 months 96 percent of cases had closure,whereas only 80 percent of control had closure. Thus Our study shows that
autologous platelet concentrates accelerates the tympanic membrane closure
3.
                       Among cases, only one failure is noted which is due to infection.
Among controls, 5 failures were noted 4 of them due to graft displacement and one
due to infection. According to   Maria Luisa Navarrete Alvaro use of platelet rich
plasma during myringoplasty will prevent graft displacement, which is seen in our
study also
(2)(3)(6)(7).
 CONCLUSION
               Platelet rich plasma is a cheap and cost effective platelet concentrate with
enriched growth factors. It accelerates the tympanic membrane closure following
myringoplasty. It prevents graft displacement. It improves the overall success rate
of myringoplasty. It has no noticeable side effects. 
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